cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.48597/k8r9-h95t
title: Measurement of Inorganics in precipitation at Leba

description: Measurement of Inorganics in precipitation at Leba
DOI: 10.48597/wumq-6un4
title: Calcium at Sniezka

description: Measurement of Calcium at Sniezka
DOI: 10.48597/66ft-pqzx
title: Measurement of Sulphate_total at Leba

description: Measurement of Sulphate_total at Leba
DOI: 10.48597/6cfc-bnm8
title: Measurement of Potassium at Jarczew

description: Measurement of Potassium at Jarczew
DOI: 10.48597/a8m5-5k6m
title: Measurement of Calcium at Sniezka

description: Measurement of Calcium at Sniezka
DOI: 10.48597/asad-wkjv
title: Measurement of Potassium at Leba

description: Measurement of Potassium at Leba
DOI: 10.48597/k3uq-zgsk
title: Measurement of Sodium at Leba

description: Measurement of Sodium at Leba
DOI: 10.48597/z9xe-rxz5
title: Measurement of Ammonium at Leba

description: Measurement of Ammonium at Leba
DOI: 10.48597/3a5u-tv2n
title: Inorganics in precipitation at Jarczew

description: Measurement of Inorganics in precipitation at Jarczew
DOI: 10.48597/yh8r-tge9
title: Inorganics in precipitation at Jarczew

description: Measurement of Inorganics in precipitation at Jarczew
DOI: 10.48597/5bxv-nmrg
title: Measurement of Magnesium at Sniezka

description: Measurement of Magnesium at Sniezka
DOI: 10.48597/9tgj-mnsr
title: Measurement of Inorganics in precipitation at Jarczew

description: Measurement of Inorganics in precipitation at Jarczew
DOI: 10.48597/w47k-3uw8
title: Measurement of Inorganics in precipitation at Jarczew

description: Measurement of Inorganics in precipitation at Jarczew
DOI: 10.48597/z4ud-9vtk
title: Measurement of Ammonium at Sniezka

description: Measurement of Ammonium at Sniezka
DOI: 10.48597/hjv4-syaw
title: Measurement of Precipitation_amount at Jarczew

description: Measurement of Precipitation_amount at Jarczew
DOI: 10.7910/dvn/85szdk
title: ACS Poverty Ratio for Domain Generalization

description: This product uses the Census Bureau Data API but is not endorsed or certified by the Census Bureau.

This dataset is a preprocessed version of the American Community Survey (ACS) 2018 Public Use Microdata Sample (PUMS), provided by the U.S. Census Bureau. It is designed for machine learning research on domain generalization. The task is to predict individual poverty ratio based on demographic and socioeconomic features, with age group used to define domain splits.

Preprocessing was adapted from the Whyshift repository (https://github.com/namkoong-lab/whyshift), which builds on the Folktables project (https://github.com/socialfoundations/folktables). Folktables provides tools to extract and structure ACS PUMS data.

The data remains governed by the U.S. Census Bureau terms of service, available at: https://www.census.gov/data/developers/about/terms-of-service.html.
DOI: 10.5281/zenodo.15388105
title: Air Quality data (PM2.5) from low-cost sensors in Athens (Keratsini, Glyfada & Thissio) in .netcdf format

description: This dataset contains timeseries calibrated PM2.5 data from 5 low cost sensors in Athens in the locations of Keratsini, Glyfada & Thissio.
DOI: 10.5281/zenodo.15388106
title: Air Quality data (PM2.5) from low-cost sensors in Athens (Keratsini, Glyfada & Thissio) in .netcdf format

description: This dataset contains timeseries calibrated PM2.5 data from 5 low cost sensors in Athens in the locations of Keratsini, Glyfada & Thissio.
DOI: 10.7910/dvn/iun1gs
title: Dataset on dynamic grid emissions considering regional variations of the energy mix in electricity grids for 2024

description: This dataset provides the average dynamic grid emission factors considering regional variations of the energy mix in electricity grids from multiple cities worldwide for 2024. The datasets from [1] were used to estimate the average dynamic grid emission factors in gCO2eq. Methodology from existing studies like [2,3] was used to create the table representing dynamic grid emission factors averaged by hours per day of each month.
[1] Electricity Maps. (2024). Granular electricity data for scope 2 carbon accounting. Copenhagen, Denmark. version Jan. 26, 2025. [Online]. Available at: https://ww2.electricitymaps.com/. Accessed on Feb. 12, 2025.
[2] Hepf, C., Bausch, K., Lauss, L., Koth, S. C., & Auer, T. (2022). Impact of dynamic emission factors of the German electricity mix on the greenhouse gas balance in building operation. Buildings, 12(12). https://doi.org/10.3390/buildings12122215. 
[3] Peters, J. F., Iribarren, D., Juez Martel, P., & Burguillo, M. (2022). Hourly marginal electricity mixes and their relevance for assessing the environmental performance of installations with variable load or power. Science of The Total Environment, 843, 156963. https://doi.org/10.1016/j.scitotenv.2022.156963. (2024-11-18)
DOI: 10.6084/m9.figshare.29071052.v1
title: Supplementary Material for: Battery Longevity in Deep Brain Stimulation for Parkinson's Disease

description: Introduction: In patients receiving deep brain stimulation (DBS) therapy, the longevity of the implanted pulse generator (IPG) is influenced by multiple factors, including patient diagnosis, therapeutic target, neurostimulator type, number of implanted leads, and stimulation settings. Recent advancements in DBS technology include longer-lived batteries, both standard and rechargeable. This study assesses the estimated IPG longevity of Medtronic, inc. Percept™ PC neurostimulator in Parkinson's Disease (PD) and explores factors associated with IPG lifespan. 
Methods: Retrospective analysis of Percept™ devices in 31 PD patients who underwent bilateral DBS targeting either the internal globus pallidus or the subthalamic nucleus. The analysis included demographics, clinical information, stimulation settings, lead locations, and Total Effective Energy Delivered (TEED). 
Results: The median IPG longevity was 75.9 months (51.6–92.3). Among stimulation parameters, frequency demonstrated the strongest inverse correlation with longevity (r=-0.49, p &lt; 0.01), followed by pulse width (r=-0.39, p &lt; 0.01), TEED (r=-0.35, p = p &lt; 0.01), current amplitude (r=-0.33, p &lt; 0.01) and voltage (r=-0.25, p = 0.04), regardless of laterality. In STN-targeted patients, a significant association was observed between the Z-coordinate of the right lead and the presence of side effects (p = 0.04). Monopolar stimulation on the dominant side showed significantly longer IPG longevity compared to bipolar stimulation (80.6 vs 49.6 months, p = 0.01). 
Conclusion: Significant negative correlations were observed between longevity and various stimulation parameters regardless of laterality. Monopolar stimulation on the dominant side was associated with increased longevity.
DOI: 10.6084/m9.figshare.29071061.v1
title: Supplementary Material for: Improved diagnosis of glioblastoma, IDH-wildtype, metastasis through molecular and DNA methylation profiling: Two case reports

description: Glioblastoma, the most common primary malignant brain tumor in adults, accounts for approximately 50% of primary malignant brain tumors. Extracranial metastases are extremely rare, affecting &lt;0.5% of patients. This article describes two cases where Next-Generation Sequencing and DNA methylation profiling, confirmed extracranial metastases of glioblastoma, IDH-WT. The first case involves a 77-year-old man who developed lung and liver mass within months of diagnosis. While both biopsies revealed undifferentiated malignant tumor, identical genetic mutations on the lung biopsy and DNA methylation profiling on the liver biopsy confirmed glioblastoma metastases. The second case details a 75-year-old women diagnosed with glioblastoma, IDH-WT who presented diffuse bone infiltration. Bone marrow aspirate and bone marrow biopsy associated with NGS and methylation profiling confirmed glioblastoma metastasis. Both patients succumbed within 8 months. These cases underscore the importance of molecular diagnostics in identifying glioblastoma metastases and guiding treatment, particularly in rare presentations involving extracranial spread.
DOI: 10.6084/m9.figshare.29071052
title: Supplementary Material for: Battery Longevity in Deep Brain Stimulation for Parkinson's Disease

description: Introduction: In patients receiving deep brain stimulation (DBS) therapy, the longevity of the implanted pulse generator (IPG) is influenced by multiple factors, including patient diagnosis, therapeutic target, neurostimulator type, number of implanted leads, and stimulation settings. Recent advancements in DBS technology include longer-lived batteries, both standard and rechargeable. This study assesses the estimated IPG longevity of Medtronic, inc. Percept™ PC neurostimulator in Parkinson's Disease (PD) and explores factors associated with IPG lifespan. 
Methods: Retrospective analysis of Percept™ devices in 31 PD patients who underwent bilateral DBS targeting either the internal globus pallidus or the subthalamic nucleus. The analysis included demographics, clinical information, stimulation settings, lead locations, and Total Effective Energy Delivered (TEED). 
Results: The median IPG longevity was 75.9 months (51.6–92.3). Among stimulation parameters, frequency demonstrated the strongest inverse correlation with longevity (r=-0.49, p &lt; 0.01), followed by pulse width (r=-0.39, p &lt; 0.01), TEED (r=-0.35, p = p &lt; 0.01), current amplitude (r=-0.33, p &lt; 0.01) and voltage (r=-0.25, p = 0.04), regardless of laterality. In STN-targeted patients, a significant association was observed between the Z-coordinate of the right lead and the presence of side effects (p = 0.04). Monopolar stimulation on the dominant side showed significantly longer IPG longevity compared to bipolar stimulation (80.6 vs 49.6 months, p = 0.01). 
Conclusion: Significant negative correlations were observed between longevity and various stimulation parameters regardless of laterality. Monopolar stimulation on the dominant side was associated with increased longevity.
DOI: 10.48597/4k4j-wx3y
title: Chloride at Leba

description: Measurement of Chloride at Leba
DOI: 10.48597/efth-zp4v
title: pH at Sniezka

description: Measurement of pH at Sniezka
DOI: 10.48597/qsh4-66dg
title: Measurement of Chloride at Leba

description: Measurement of Chloride at Leba
DOI: 10.48597/5k4r-bqdn
title: Inorganics in precipitation at Jarczew

description: Measurement of Inorganics in precipitation at Jarczew
DOI: 10.48597/mda8-mmc6
title: Measurement of pH at Sniezka

description: Measurement of pH at Sniezka
DOI: 10.48597/uph5-u4zh
title: Measurement of Chloride at Jarczew

description: Measurement of Chloride at Jarczew
DOI: 10.48597/zd64-afsn
title: Measurement of Inorganics in precipitation at Jarczew

description: Measurement of Inorganics in precipitation at Jarczew
DOI: 10.6084/m9.figshare.29071061
title: Supplementary Material for: Improved diagnosis of glioblastoma, IDH-wildtype, metastasis through molecular and DNA methylation profiling: Two case reports

description: Glioblastoma, the most common primary malignant brain tumor in adults, accounts for approximately 50% of primary malignant brain tumors. Extracranial metastases are extremely rare, affecting &lt;0.5% of patients. This article describes two cases where Next-Generation Sequencing and DNA methylation profiling, confirmed extracranial metastases of glioblastoma, IDH-WT. The first case involves a 77-year-old man who developed lung and liver mass within months of diagnosis. While both biopsies revealed undifferentiated malignant tumor, identical genetic mutations on the lung biopsy and DNA methylation profiling on the liver biopsy confirmed glioblastoma metastases. The second case details a 75-year-old women diagnosed with glioblastoma, IDH-WT who presented diffuse bone infiltration. Bone marrow aspirate and bone marrow biopsy associated with NGS and methylation profiling confirmed glioblastoma metastasis. Both patients succumbed within 8 months. These cases underscore the importance of molecular diagnostics in identifying glioblastoma metastases and guiding treatment, particularly in rare presentations involving extracranial spread.
DOI: 10.6084/m9.figshare.29071058.v1
title: Supplementary Material for: The Moderating Effect of Oral Health Literacy on the Relationship Between Socioeconomic Conditions and Untreated Dental Caries in Pregnant Women

description: Introduction: Dental caries is highly prevalent among pregnant women, and investigating potential modifying factors is particularly relevant for this population. This study aimed to evaluate the moderating effect of oral health literacy (OHL) on the relationship between socioeconomic conditions and dental caries in pregnant women. Methods: This cross-sectional study was performed with pregnant women attending the public health service in Santa Maria, a municipality in Southern Brazil. The Brazilian Rapid Estimate of Adult Literacy in Dentistry (BREALD-30) instrument was used to evaluate OHL. The presence of dental caries was measured using the Decayed, Missing, or Filled Teeth (DMFT) index. Socioeconomic conditions were assessed based on family income and education level. The moderating effect of OHL on the relationship between income, education, and caries (D component of DMFT) was tested using multilevel Poisson regression analyses. The results are presented as Prevalence Ratio (PR). Results: A total of 520 pregnant women were examined (response rate of 93%). Pregnant women with low educational level and low OHL exhibited a 69% higher prevalence of dental caries compared to those with higher education and high OHL. Similarly, among those with high income, pregnant with low OHL had a 57% higher prevalence of untreated dental caries than their counterparts with both high income and high OHL. Conclusion: Our findings indicate that low OHL modifies the association between socioeconomic conditions and dental caries among pregnant women. Low OHL appears to function as an aggravating factor, potentially exacerbating oral health outcomes in this population.
DOI: 10.6084/m9.figshare.29071058
title: Supplementary Material for: The Moderating Effect of Oral Health Literacy on the Relationship Between Socioeconomic Conditions and Untreated Dental Caries in Pregnant Women

description: Introduction: Dental caries is highly prevalent among pregnant women, and investigating potential modifying factors is particularly relevant for this population. This study aimed to evaluate the moderating effect of oral health literacy (OHL) on the relationship between socioeconomic conditions and dental caries in pregnant women. Methods: This cross-sectional study was performed with pregnant women attending the public health service in Santa Maria, a municipality in Southern Brazil. The Brazilian Rapid Estimate of Adult Literacy in Dentistry (BREALD-30) instrument was used to evaluate OHL. The presence of dental caries was measured using the Decayed, Missing, or Filled Teeth (DMFT) index. Socioeconomic conditions were assessed based on family income and education level. The moderating effect of OHL on the relationship between income, education, and caries (D component of DMFT) was tested using multilevel Poisson regression analyses. The results are presented as Prevalence Ratio (PR). Results: A total of 520 pregnant women were examined (response rate of 93%). Pregnant women with low educational level and low OHL exhibited a 69% higher prevalence of dental caries compared to those with higher education and high OHL. Similarly, among those with high income, pregnant with low OHL had a 57% higher prevalence of untreated dental caries than their counterparts with both high income and high OHL. Conclusion: Our findings indicate that low OHL modifies the association between socioeconomic conditions and dental caries among pregnant women. Low OHL appears to function as an aggravating factor, potentially exacerbating oral health outcomes in this population.
DOI: 10.6084/m9.figshare.29071064
title: Supplementary Material for: Association between Pneumothorax and Neonatal Outcomes among Very Preterm Infants: A Multicenter Cohort Study

description: Introduction: We aimed to evaluate whether the incidence of pneumothorax is associated with adverse neonatal outcomes in very preterm infants.
Methods: This multicenter cohort study included all infants with a gestational age of 24 to 31 weeks, admitted to the tertiary neonatal intensive care units of the Chinese Neonatal Network, from 2019 to 2022. Pneumothorax was diagnosed via chest X-ray or lung computed tomography. The primary outcome was a composite measure of mortality and/or any severe neonatal morbidity. Multivariable logistic or linear regression analyses were performed to assess the association between pneumothorax and neonatal outcomes. Propensity score matching was used to ensure the robustness of the results.
Results: Among the 37,917 infants in the study, 465 (1.2%) developed pneumothorax. pneumothorax was significantly associated with a higher risk of mortality and/or severe neonatal morbidity (adjusted odds ratio = 3.15, 95% confidence interval: 2.36, 4.20). Pneumothorax exposure was also independently associated with increased mortality, severe intraventricular haemorrhage, moderate or severe bronchopulmonary dysplasia, and the need for invasive ventilation and its duration. Additionally, pneumothorax was associated with an increased length of hospital stay among survivors (adjusted odds ratio = 7.62, 95% confidence interval: 4.33, 10.91). The usage of high-frequency invasive mechanical ventilation before pneumothorax and pneumothorax treated with an intercostal chest drain seemed to have the most significant harmful effect (adjusted odds ratios were 3.34 and 3.27 respectively). 
Conclusion: Our study underscores the significant impact of pneumothorax on increasing mortality and severe morbidities in very preterm infants.
DOI: 10.6084/m9.figshare.29071055
title: Supplementary Material for: Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

description: Backgrounds: Immune checkpoint inhibitors (ICIs) have improved lung cancer treatment but are associated with an increased risk of cardiotoxicity. We investigated whether statins could mitigate ICI-associated cardiovascular risks in lung cancer patients.
Methods: We performed a retrospective, propensity score-matched cohort study utilizing the TriNetX database. We identified lung cancer patients receiving ICIs between April 2013 and June 2023. We created two cohorts: statin users and non-users. The primary efficacy outcome was major adverse cardiovascular events (MACE), defined as a composite of myocardial infarction, ischemic stroke, and heart failure. The secondary efficacy outcomes were myocarditis and cardiac arrest. Safety outcomes were all-cause mortality and serious immune-related adverse events (irAEs).
Results: A total of 16,650 lung cancer patients undergoing ICIs were identified, consisting of 6,812 statin users and 9,838 non-users. After propensity score matching, 4,379 patients were well-matched in baseline characteristics. Over a follow-up period of 12 months, statin use was associated with a lower risk of MACE (HR: 0.87, 95% CI: 0.78-0.98), primarily driven by reductions in myocardial infarction (HR: 0.75, 95% CI: 0.58-0.97) and heart failure (HR: 0.85, 95% CI: 0.74-0.98). For safety outcomes, statin use was associated with a reduction in all-cause mortality (HR: 0.83, 95% CI: 0.77-0.90) and did not result in an increased risk of serious irAEs.
Conclusions: The use of statins in lung cancer patients with cardiovascular risk factors and without previous cardiovascular events undergoing immunotherapy was associated with a reduction in MACE and all-cause mortality without an increased risk of serious adverse events.
DOI: 10.6084/m9.figshare.29071055.v1
title: Supplementary Material for: Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

description: Backgrounds: Immune checkpoint inhibitors (ICIs) have improved lung cancer treatment but are associated with an increased risk of cardiotoxicity. We investigated whether statins could mitigate ICI-associated cardiovascular risks in lung cancer patients.
Methods: We performed a retrospective, propensity score-matched cohort study utilizing the TriNetX database. We identified lung cancer patients receiving ICIs between April 2013 and June 2023. We created two cohorts: statin users and non-users. The primary efficacy outcome was major adverse cardiovascular events (MACE), defined as a composite of myocardial infarction, ischemic stroke, and heart failure. The secondary efficacy outcomes were myocarditis and cardiac arrest. Safety outcomes were all-cause mortality and serious immune-related adverse events (irAEs).
Results: A total of 16,650 lung cancer patients undergoing ICIs were identified, consisting of 6,812 statin users and 9,838 non-users. After propensity score matching, 4,379 patients were well-matched in baseline characteristics. Over a follow-up period of 12 months, statin use was associated with a lower risk of MACE (HR: 0.87, 95% CI: 0.78-0.98), primarily driven by reductions in myocardial infarction (HR: 0.75, 95% CI: 0.58-0.97) and heart failure (HR: 0.85, 95% CI: 0.74-0.98). For safety outcomes, statin use was associated with a reduction in all-cause mortality (HR: 0.83, 95% CI: 0.77-0.90) and did not result in an increased risk of serious irAEs.
Conclusions: The use of statins in lung cancer patients with cardiovascular risk factors and without previous cardiovascular events undergoing immunotherapy was associated with a reduction in MACE and all-cause mortality without an increased risk of serious adverse events.
DOI: 10.6084/m9.figshare.29071067
title: Supplementary Material for: Time in target range of systolic blood pressure and cardiovascular disease in patients with chronic kidney disease: A Korean nationwide cohort study

description: Introduction: Time in target range of systolic blood pressure (SBP-TTR) is the percentage of time that the SBP remains within 110–130 mmHg. The association between the SBP-TTR and clinical outcomes in patients with chronic kidney disease (CKD) remains unclear. We evaluated the risks of cardiovascular disease (CVD), all-cause mortality, and renal events across the SBP-TTR groups.
Methods: Overall, 193,289 patients with CKD who underwent at least two health checkups between 2012 and 2015 were selected from the Korean National Health Insurance Database. The patients were categorized into three categories based on their SBP-TTR levels: 76–100%, 26–75%, and 0–25%. The primary outcome was CVD risk and the secondary outcomes were all-cause mortality and progression to end-stage kidney disease (ESKD) according to SBP-TTR using Cox regression analysis.
Results: Compared with patients with SBP-TTR of 76–100%, the adjusted hazard ratios (HRs) for CVD were 1.07 (95% confidence interval [CI], 1.03–1.10) and 1.09 (95% CI, 1.06–1.13) for patients with SBP-TTR of 26–75%, and 0–25%, respectively. The adjusted HR for all-cause mortality was 1.04 (95% CI, 1.003–1.07) and 1.37 (95% CI, 1.28–1.46) for patients with SBP-TTR of 26–75% and 0–25%, respectively. The adjusted HRs for ESKD progression increased gradually: 1.14-fold (95% CI, 1.07–1.21) for the SBP-TTR 26–75% group and 1.37-fold (95% CI, 1.28–1.46) for the SBP-TTR 0–25% group. For patients not taking antihypertensive medications, a lower SBP-TTR was associated with a higher risk of CVD events and ESKD progression than in those taking antihypertensive medications.
Conclusions: Among patients with CKD, those with a lower SBP-TTR had a higher risk of cardiovascular events, mortality, and progression to ESKD.